Microfluidic-based Tactile Sensor in Cardiac Rehabilitation
Status unconfirmed
Conditions studied: Cardiovascular Diseases, Vascular Stiffness, Endothelial Dysfunction
In brief
This study will examine the impact of cardiac rehabilitation on blood vessel health using a newly developed microfluidic-based tactile sensor to assess blood vessel health. The participants will have their blood vessel health measured using a sensor that is placed on top of the skin over the artery before and after exercise (1, 3, 5, 10, 30 and 60 mins). The investigators will study these responses at the first session of cardiac rehabilitation and following 1 and 4 weeks of cardiac rehabilitation (sessions 3 and 6). The investigators will also collect some information from the medical record regarding: age, gender, body mass index, resting cardiovascular measures (heart rate, blood pressure etc), medications, reasons which qualified the participant into cardiac rehabilitation, blood tests related to heart or cardiovascular function, metabolic panel, lipid panel, echocardiogram results, recorded electrocardiogram, known vascular diseases, presence of implantable devices, Seattle Heart Failure Model data and cardiovascular measures and exercise workloads during cardiac rehabilitation.
Key facts
- Study ID
- NCT04812600
- Run by
- Zhili hao
- People needed
- 30
- Starts
- 2021-03-20
- Expected to finish
- 2022-03-20
- Last updated by the study team
- 2021-03-23
Who can join
Age: 45 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 45-70
- Subjects who qualify for cardiac rehabilitation via doctor's orders
You may not qualify if…
- ●Physical limitations which would preclude one from performing exercise.
Where it is running
- Sentara Heart Hospital — Norfolk, Virginia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.